Proposed trial: safety and efficacy of resveratrol for the treatment of non-alcoholic fatty liver disease (NAFLD) and associated insulin resistance in adolescents who are overweight or obese adolescents -- rationale and protocol.
| Autor: | Wicklow, Brandy1,2 bwicklow@hsc.mb.ca, Wittmeier, Kristy1,3,4,5, ť Jong, Geert W.1,2,6,7, McGavock, Jonathon1,2, Robert, Marni5, Duhamel, Todd2,8,9, Dolinsky, Vernon W.2,6 |
|---|---|
| Zdroj: | Biochemistry & Cell Biology. 2015, Vol. 93 Issue 5, p522-530. 9p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|